# FDA recall D-001-2014

> **Teva Pharmaceuticals USA** · Class II · drug recall initiated 2013-10-24.

## Product

Copaxone (glatiramer acetate injection), 20 mg/1 mL, 1 mL pre-filled syringe, packaged in 30 single-use PRE-FILLED Syringes and 33 Alcohol Preps (Swabs) per carton, Rx only, Marketed by: Teva Neuroscience, Inc., Kansas City, MO  64131; Distributed by: Teva Pharmaceuticals USA, Inc., North Wales, PA  19454, NDC 68546-317-30, UPC 3 68546 31730 4.

## Reason for recall

Presence of Particulate Matter: A foreign particle found in a pre-filled syringe was reported through a consumer complaint about a pre-filled syringe.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-001-2014
- **Recalling firm:** Teva Pharmaceuticals USA
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-10-24
- **Report date:** 2013-11-27
- **Termination date:** 2014-08-27

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Horsham, PA, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-001-2014

## Citation

> AI Analytics. FDA recall D-001-2014. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-001-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*